Abbott Laboratories (ABT:NYSE) closed at $102.51 on October 22, 2026, up 1.99% on the day. The stock trades 22.4% below its 52-week high of $132.03 and 25.1% above its 52-week low of $81.97. Over the past year, it lost 18.9%. Abbott Laboratories is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 22, 2025, ABT closed higher on 119 days (47%). Its best day was July 16, 2026 (+10.71%) and its worst was January 22, 2026 (-10.04%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 1 time.
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and a suite of informatics tools and professional services...
Find more stocks like ABT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.